WO2015192834A2 - Procédé de production d'une substance consommable conçue pour se vaporiser - Google Patents

Procédé de production d'une substance consommable conçue pour se vaporiser Download PDF

Info

Publication number
WO2015192834A2
WO2015192834A2 PCT/DE2015/100243 DE2015100243W WO2015192834A2 WO 2015192834 A2 WO2015192834 A2 WO 2015192834A2 DE 2015100243 W DE2015100243 W DE 2015100243W WO 2015192834 A2 WO2015192834 A2 WO 2015192834A2
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
liquid
consumable
tea
active
Prior art date
Application number
PCT/DE2015/100243
Other languages
German (de)
English (en)
Other versions
WO2015192834A3 (fr
Inventor
Klaus Hagen
Original Assignee
Klaus Hagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klaus Hagen filed Critical Klaus Hagen
Publication of WO2015192834A2 publication Critical patent/WO2015192834A2/fr
Publication of WO2015192834A3 publication Critical patent/WO2015192834A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/22—Treatment of tobacco products or tobacco substitutes by application of electric or wave energy or particle radiation

Definitions

  • the invention relates to a process for producing a consumable provided for evaporation in electronic cigarettes, a base liquid and at least one active ingredient.
  • the invention also relates to a consumable for use in electronic cigarettes as well as drugs and drug mixtures for such a consumable.
  • the base liquid and the active substance (s) are incubated together under the influence of heat and expediently in a closed vessel.
  • the required amount of active substance (s) will initially be on a
  • the amount of active ingredient is quantitatively transferred to a container in which the base liquid is already held.
  • the active ingredient in its initial state is added to a base liquid already stored in a vessel.
  • emulsifiers as auxiliaries can not be mixed with each other immiscible substances to a finely divided mixture, an emulsion, and stabilized, for.
  • water and fat-soluble drugs It is therefore recommended that an emulsifier be added to the base liquid or active substance, by means of which it is possible to combine different active ingredients into a liquid formula and thereby to optimize the desired effect.
  • Process step is incubated in a heated ultrasonic bath in several cycles. As a heating medium is therefore recommended as an ultrasonic bath. The number and duration of the cycles must be adapted to the active ingredients used.
  • Process solution is incubated in a sealed vessel in a second process step in an at least approximately room temperature having liquid bath until the solution in about the
  • Temperature of the liquid bath has assumed. This is done by the vessel is incubated in a second, corresponding to a cooling process step in a liquid, preferably water bath at room temperature.
  • the temperature of the liquid is approx. 17 ° C to 25 ° C, which must be ensured by suitable measures.
  • the aim of this second process step is to prevent the crystallization during the cooling process and thus to avoid solidification of the liquid in the vessel.
  • the decisive factor here is that the solubility of the active ingredients significantly improved by the addition of acids or alkalis and thus the concentration of the respective active ingredient can be significantly increased.
  • Process step is carried out until the nicotine-free consumable has approximately reached the temperature of the liquid bath.
  • the finished product in the form of the consumable is then stored as possible at room temperature. It can be filled at any time into the liquid containers provided for electronic cigarettes and then consumed.
  • a particularly effective and at the same time healthy consumable is achieved in order to optimize the desired effects in the body and to develop a particularly targeted effect.
  • the alternative that is dispensed with the influence of heat and it comes to a simple mixing, possibly caused by shaking, stirring and / or at most slight heating or supported.
  • Another alternative provides that the active ingredient is isolated on the
  • Base liquid is applied and that the base liquid together with the active ingredient is then heated so much that the active ingredient at least approximately reaches its specific boiling point. It is natural to note that the respective
  • Active ingredient to reach its specific boiling point, but must not exceed. Rather, it applies that the active ingredients just mix with the evaporating water, without being decomposed or destroyed.
  • any legally available, legally approved and health-compatible substances are usable, which in the Are able to produce a special effect in an organism or to cause a special reaction.
  • Particularly well-known in this context is the caffeine known for its modest effect, while nicotine is expressly to be excluded since, in contrast to the above-mentioned active substances, it must be classified as questionable from both a medical and a social point of view.
  • a drug mixture as a starting material for a consumable for use in electronic cigarettes with a
  • the active ingredient mixture is nicotine-free. Nicotine is a very controversial inequality especially with regard to health and dependence and is completely replaced in the context of the solution according to the invention. If the active ingredient mixture has a proportion of 50% to 100% tea, especially matcha tea, this unfolds a similar overall effect as the offended nicotine, only it is just much healthier.
  • this drug mixture consists of the active ingredients tea and / or a variety of green tea. It has an invigorating, but also calming effect, especially due to the ingredient contained in green tea caffeine, which is mainly due to the L-theanine contained in green tea. In addition, it promotes concentration and breaks down toxic substances in the body. For the special variety Matcha tea, the concentration of o. A. Ingredients particularly high. The mixture itself consists, in addition to a base liquid, therefore from 50-100% tea and / or green tea or Matcha tea.
  • the active substance mixture has aromas.
  • flavors that may serve as flavor enhancers such as coffee flavor
  • flavors that may serve as flavor enhancers such as tea flavor.
  • a preferred embodiment of the invention provides that the
  • Active ingredient from the group of stimulants (caffeine, guarana, taurine, ginko, sugar, ginseng, mate tea, matcha tea, vitamins, goji berry, green tea, white tea, kava kava, lobelia, etc.) is derived.
  • the active ingredient from the group of soothing active ingredients (lemon balm, L-theanine, minerals, zinc, Gingseng, ginger, lavender, valerian, lemon balm, etc .). Also conceivable are combinations of soothing and invigorating active ingredients.
  • the invention is characterized in particular by the fact that a method for producing a nicotine-free consumable intended for evaporation in electronic cigarettes is provided in three variants.
  • the consumable is prepared by mixing, stirring, shaking and / or heating.
  • a second variant teaches a process for producing a consumable used for evaporation in electronic cigarettes, which enables special input concentrations.
  • steam distillation is particularly suitable, in which the active ingredient in its solid or liquid starting state is added to a base liquid already stored in a vessel.
  • active ingredients caffeine, taurine, tea, L-theanine, vitamins, lemon balm, lavender, valerian, minerals, zinc, ginseng, ginger, etc. are mainly used.
  • the basic liquids are mainly propylene glycol, glycerine and water.
  • propylene glycol for the application of the chiral dihydric alcohol propylene glycol in the base liquid, an enantiomeric purity is not required. It can be used the racemate.
  • base liquid and active ingredient (s) are expediently incubated in a heated ultrasonic bath in several cycles under the influence of heat.
  • the consumable is then cooled and transferred to the storable final state.
  • a third Procedure provides that the base liquid together with the active ingredient (s) is heated to such an extent that they reach approximately their specific boiling point with the help of this dry evaporation.
  • the active ingredient Depending on the solubility of the active ingredient (s), it may be necessary to make the combined ingredients more soluble by simply stirring, shaking, and or heating, thereby increasing the level of effect.
  • the resulting consumable is suitable both for use in disposable electric cigarettes in the form of so-called disposables and for the operation of rechargeable and rechargeable electric cigarettes, so-called rechargeables.
  • FIG. 1 shows a container 1 with different molecules, namely
  • Figure 2 shows the dry evaporation in the
  • Container 1 The active ingredient 3 is applied in isolation and begins with a

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)

Abstract

Selon un procédé de production d'une substance consommable conçue pour se vaporiser dans des cigarettes électroniques, un liquide de base et un principe actif sont incubés ensemble.
PCT/DE2015/100243 2014-06-18 2015-06-17 Procédé de production d'une substance consommable conçue pour se vaporiser WO2015192834A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014108584.1 2014-06-18
DE102014108584.1A DE102014108584B4 (de) 2014-06-18 2014-06-18 Verfahren zur Herstellung eines zur Verdampfung vorgesehenen Verbrauchsstoffs

Publications (2)

Publication Number Publication Date
WO2015192834A2 true WO2015192834A2 (fr) 2015-12-23
WO2015192834A3 WO2015192834A3 (fr) 2016-04-14

Family

ID=53776261

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2015/100243 WO2015192834A2 (fr) 2014-06-18 2015-06-17 Procédé de production d'une substance consommable conçue pour se vaporiser

Country Status (2)

Country Link
DE (1) DE102014108584B4 (fr)
WO (1) WO2015192834A2 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10045567B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10045568B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10058130B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US10104915B2 (en) 2013-12-23 2018-10-23 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
US10111470B2 (en) 2013-12-23 2018-10-30 Juul Labs, Inc. Vaporizer apparatus
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
US10512282B2 (en) 2014-12-05 2019-12-24 Juul Labs, Inc. Calibrated dose control
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
USD913583S1 (en) 2016-06-16 2021-03-16 Pax Labs, Inc. Vaporizer device

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
DE202017007467U1 (de) 2016-02-11 2021-12-08 Juul Labs, Inc. Befüllbare Verdampferkartusche
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2183966C1 (ru) * 2001-07-06 2002-06-27 Общество с ограниченной ответственностью "Сибларекс" Состав биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий и способ получения биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий
BRPI1011878B1 (pt) * 2009-04-28 2019-07-30 Kao Corporation Processo para produzir uma solução de extrato de café concentrado
JP2012105642A (ja) * 2010-10-27 2012-06-07 Kao Corp コーヒー抽出液の製造方法
HUE026804T2 (en) * 2011-02-11 2016-07-28 Batmark Ltd Inhaler component
CN102349699B (zh) * 2011-07-04 2013-07-03 郑俊祥 一种电子烟液的制备方法
CN103336086B (zh) * 2013-07-25 2015-07-08 湖北中烟工业有限责任公司 咖啡豆药材中挥发油化学成分的分析方法
CN104126874A (zh) * 2014-07-11 2014-11-05 张伟滨 一种电子烟雾化液及其制备方法
CN104450186B (zh) * 2014-10-29 2017-04-19 山东中烟工业有限责任公司 一种电子烟烟液用烟草本香物质的制备方法
CN104531351B (zh) * 2014-12-03 2017-08-08 河南中烟工业有限责任公司 一种电子烟烟液用添加剂及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US10638792B2 (en) 2013-03-15 2020-05-05 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10111470B2 (en) 2013-12-23 2018-10-30 Juul Labs, Inc. Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10070669B2 (en) 2013-12-23 2018-09-11 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US10104915B2 (en) 2013-12-23 2018-10-23 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US10117466B2 (en) 2013-12-23 2018-11-06 Juul Labs, Inc. Vaporization device systems and methods
US10058124B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US10201190B2 (en) 2013-12-23 2019-02-12 Juul Labs, Inc. Cartridge for use with a vaporizer device
US11752283B2 (en) 2013-12-23 2023-09-12 Juul Labs, Inc. Vaporization device systems and methods
US10058130B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10264823B2 (en) 2013-12-23 2019-04-23 Juul Labs, Inc. Vaporization device systems and methods
US10045568B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10912331B2 (en) 2013-12-23 2021-02-09 Juul Labs, Inc. Vaporization device systems and methods
US10667560B2 (en) 2013-12-23 2020-06-02 Juul Labs, Inc. Vaporizer apparatus
US10045567B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10512282B2 (en) 2014-12-05 2019-12-24 Juul Labs, Inc. Calibrated dose control
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
USD913583S1 (en) 2016-06-16 2021-03-16 Pax Labs, Inc. Vaporizer device
USD929036S1 (en) 2016-06-16 2021-08-24 Pax Labs, Inc. Vaporizer cartridge and device assembly
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge

Also Published As

Publication number Publication date
DE102014108584A1 (de) 2015-12-24
WO2015192834A3 (fr) 2016-04-14
DE102014108584B4 (de) 2016-09-01

Similar Documents

Publication Publication Date Title
DE102014108584B4 (de) Verfahren zur Herstellung eines zur Verdampfung vorgesehenen Verbrauchsstoffs
WO2015091346A2 (fr) Produit succédané de tabac
EP2862454A1 (fr) Composition liquide pour cigarette électronique
DE60015847T2 (de) Flüssige Zubereitung zum Verdampfen gegen Erhöhung des Blutzuckerspiegels und Verdampfer für dieselbe
US20220071910A1 (en) Cannabidiol Dosage Form
DE2445354B2 (de) Verfahren zur extraktion von antioxidantien
DE3435325A1 (de) Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
DE102014202318B4 (de) Verbessertes Verfahren zur Herstellung von Ginkgoextrakten
EP1431385A1 (fr) Boisson contenant du xanthohumol
DE2931395C2 (fr)
DE1692269A1 (de) Verfahren und Vorrichtung zur Herstellung von Extraktpulver aus Kaffee od.dgl.
Godwin et al. Determination of elemental, phenolic, antioxidant and flavonoid properties of Lemon grass (Cymbopogon citratus Stapf).
KR101623426B1 (ko) 무화기용 액상 조성물 및 그의 제조방법
EP0224157A1 (fr) Préparations orales d'ail et leur procédé de fabrication
CN103877602A (zh) 红豆杉固体空气清新剂及其制造配方和制造方法
EP2608798B2 (fr) Extraits végétaux de sideritis et leur utilisation pour augmenter les performances cognitives
DE69917446T2 (de) Verfahren zum Herstellen von Kapseln und Tabletten aus Naturstoffen pflanzlichen Ursprungs
DE1617810A1 (de) Verfahren und Vorrichtung zur Herstellung von Knoblauchpraeparaten
DE19729143C2 (de) Kräuterpflegesalbe
DE19800330C2 (de) Pharmazeutisch wirksamer CO¶2¶-Extrakt aus Tanacetum parthenium
DE102014213548A1 (de) Cannabispräparat
DE10345343A1 (de) Verfahren zur Herstellung eines Extrakts aus Efeublättern und nach diesem Verfahren hergestellter Extrakt
DE3905033C2 (fr)
CN103877600A (zh) 含有红豆杉提取物的喷雾剂及其制造方法和制造配方
EP3984522A1 (fr) Composition, dispositif et utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15745378

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 15745378

Country of ref document: EP

Kind code of ref document: A2